The Latest From CureMatch
CureMatch’s decision support system is up and running and leading the way to change the landscape for Precision Medicine Leaders around the globe; with initial focus on combination therapies to empower oncologists to treat cancer using genomics. At San Diego’s Hilton Bayfront, August 21-24, 2017, learn how CureMatch has combined super computing power and data […]
SAN DIEGO, CA – August 18, 2017 –CureMatch, a digital health company focusing on personalized medicine and combination therapy in oncology, today announced that it has closed its bridge round to Series A financing. CureMatch is the only company to offer a data-driven report that scores combinations of cancer drugs that are tailored for individual patients. The report is generated using CureMatch’s Decision Support System, which analyzes millions of cancer treatment options with its proprietary algorithms and evidence-based, custom-curated databases of genomics and proteomics information.
SAN DIEGO, CA – CureMatch is pleased to announce it has been selected to take part in MetroConnect 2017, an export assistance program run by the World Trade Center San Diego (WTC) and designed to help San Diego companies accelerate their global growth. The announcement will be made today by San Diego Mayor Kevin Faulconer and WTC San Diego.
CureMatch receives a new investment by Tech Entrepreneur Phil Trubey on the heels of San Diego Venture Group’s selection of CureMatch as a venture-ready company. SAN DIEGO, CA – June 14, 2017 –CureMatch, a digital health company that guides oncologists in the selection of advanced cancer therapies, today announced that Phil Trubey had joined a […]
CureMatch takes fighting pediatric cancer seriously. Seeing kids suffering from cancer when modern technology and genomics could hold the cures is not the responsible thing to do. CureMatch has been working hard to provide this decision support system to clinicians, oncologists and pediatric cancer teams around the globe. In a bold move by co-founder Blaise […]
